Skip to content

Paul T Quinlan, General Counsel at Oruka Therapeutics, sold ORKA on Aug 14, 2026

Data as of Oct 16

▼ SELL$385K3,630 shares at $106.05Paul T Quinlan General CounselORKA Oruka Therapeutics, Inc.
Watch ORKA
Traded
Aug 14, 2026
Disclosed
Aug 14, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Paul T Quinlan, General Counsel at Oruka Therapeutics, sold ORKA on Aug 14, 2026TRADEDDISCLOSED
ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day
ORKA since disclosure
−35.2%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$1.6Mdisclosed Aug 14 · filed the same day
  2. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$1Mdisclosed Aug 14 · filed the same day
  3. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$1.1Mdisclosed Aug 14 · filed the same day
  4. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$1.1Mdisclosed Aug 14 · filed the same day
  5. ▼ SELLPaul T Quinlan General CounselORKA Oruka Therapeutics, Inc.$428Kdisclosed Aug 14 · filed the same day

See every trade on ORKA →